OLMA
Price
$22.01
Change
+$2.58 (+13.28%)
Updated
Nov 20 closing price
Capitalization
1.73B
101 days until earnings call
Intraday BUY SELL Signals
VNDA
Price
$4.84
Change
-$0.30 (-5.84%)
Updated
Nov 20 closing price
Capitalization
286.03M
82 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

OLMA vs VNDA

Header iconOLMA vs VNDA Comparison
Open Charts OLMA vs VNDABanner chart's image
Olema Pharmaceuticals
Price$22.01
Change+$2.58 (+13.28%)
Volume$12.28M
Capitalization1.73B
Vanda Pharmaceuticals
Price$4.84
Change-$0.30 (-5.84%)
Volume$1.15M
Capitalization286.03M
OLMA vs VNDA Comparison Chart in %
OLMA
Daily Signal:
Gain/Loss:
VNDA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
OLMA vs. VNDA commentary
Nov 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OLMA is a Hold and VNDA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 21, 2025
Stock price -- (OLMA: $22.00 vs. VNDA: $4.84)
Brand notoriety: OLMA and VNDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OLMA: 337% vs. VNDA: 158%
Market capitalization -- OLMA: $1.73B vs. VNDA: $286.03M
OLMA [@Biotechnology] is valued at $1.73B. VNDA’s [@Biotechnology] market capitalization is $286.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.15B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OLMA’s FA Score shows that 0 FA rating(s) are green whileVNDA’s FA Score has 1 green FA rating(s).

  • OLMA’s FA Score: 0 green, 5 red.
  • VNDA’s FA Score: 1 green, 4 red.
According to our system of comparison, both OLMA and VNDA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OLMA’s TA Score shows that 7 TA indicator(s) are bullish while VNDA’s TA Score has 4 bullish TA indicator(s).

  • OLMA’s TA Score: 7 bullish, 3 bearish.
  • VNDA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, OLMA is a better buy in the short-term than VNDA.

Price Growth

OLMA (@Biotechnology) experienced а +177.08% price change this week, while VNDA (@Biotechnology) price change was +11.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.65%. For the same industry, the average monthly price growth was -7.08%, and the average quarterly price growth was +60.39%.

Reported Earning Dates

OLMA is expected to report earnings on Mar 02, 2026.

VNDA is expected to report earnings on Feb 11, 2026.

Industries' Descriptions

@Biotechnology (-1.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OLMA($1.73B) has a higher market cap than VNDA($286M). OLMA YTD gains are higher at: 277.358 vs. VNDA (1.044). VNDA has higher annual earnings (EBITDA): -113.07M vs. OLMA (-156.66M). OLMA has more cash in the bank: 362M vs. VNDA (294M). OLMA has less debt than VNDA: OLMA (4.76M) vs VNDA (10.9M). VNDA has higher revenues than OLMA: VNDA (212M) vs OLMA (0).
OLMAVNDAOLMA / VNDA
Capitalization1.73B286M605%
EBITDA-156.66M-113.07M139%
Gain YTD277.3581.04426,571%
P/E RatioN/A126.00-
Revenue0212M-
Total Cash362M294M123%
Total Debt4.76M10.9M44%
FUNDAMENTALS RATINGS
VNDA: Fundamental Ratings
VNDA
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
46

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OLMAVNDA
RSI
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
71%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
74%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
69%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 1 day ago
70%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
OLMA
Daily Signal:
Gain/Loss:
VNDA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SSSVX498.96N/A
N/A
State Street Equity 500 Index A
TWQIX16.91N/A
N/A
Transamerica Large Cap Value I
HGHFX43.15N/A
N/A
Hartford Healthcare F
RPFCX66.44-0.55
-0.82%
Davis Balanced Fund A
JIDVX12.81-0.16
-1.23%
Janus Henderson U.S. Dividend Income I

OLMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, OLMA has been loosely correlated with CRNX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if OLMA jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OLMA
1D Price
Change %
OLMA100%
+13.23%
CRNX - OLMA
43%
Loosely correlated
-2.17%
VNDA - OLMA
40%
Loosely correlated
-5.84%
ORMP - OLMA
37%
Loosely correlated
-3.01%
ARWR - OLMA
37%
Loosely correlated
-2.21%
CPRX - OLMA
36%
Loosely correlated
+1.16%
More

VNDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VNDA has been loosely correlated with APLS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if VNDA jumps, then APLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNDA
1D Price
Change %
VNDA100%
-5.84%
APLS - VNDA
43%
Loosely correlated
+0.46%
ANNX - VNDA
41%
Loosely correlated
+5.17%
ADMA - VNDA
40%
Loosely correlated
+2.57%
IVF - VNDA
40%
Loosely correlated
-16.39%
NEVPF - VNDA
38%
Loosely correlated
N/A
More